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Abstract

Bacterial LPS as the immune modulating component in
Juzen-taiho-to
By
Diego Montenegro
Advisor: Dr. Akira Kawamura

Juzen-taiho-to (JTT) is an immune-boosting herbal formulation with an ideal
balance of safety and efficacy. For example, JTT is clinically used in Japan to stimulate
the immunological functions of cancer patients undergoing chemotherapy and radiation.
Although the clinical effects of JTT are recognized, the active compounds and
mechanism of action are unknown. The studies conducted previously in our laboratory
associated several phytosterols and plant glycolipids with the potent immunostimulatory
activity of JTT: namely, β-sitosteryl β-D-glucoside (BSSG), glucocerebroside (GluCer),
digalactosyldiacylglycerol
However,

these

(DGDG)

compounds,

when

and

monogalactosyldiacylglycerol

further

purified,

exhibited

(MGDG).

little

or

no

immunostimulatory activity. This suggested that the immunostimulatory factors in JTT
(1) had similar physicochemical properties as phytosterols and glycolipids; (2) existed in
very small quantities, and (3) were extremely potent. These attributes led us to the
hypothesis that the immunostimulatory factors of JTT stemmed not from plant
metabolites but from bacterial glycolipids, some of which were known for potent
immunostimulatory activity.
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This hypothesis was tested in the first half of my thesis work. Through a series of
chemical and biochemical studies, including chemical extraction and high resolution
mass spectrometry (MS), the main immunostimulatory factor of JTT was identified as
lipopolysaccharide

(LPS)

of

Gram-negative

bacteria. Detailed

chemical

and

immunological characterization of LPS in JTT, however, was hampered by their
heterogeneity and minuscule quantities. In order to gain insights into the LPS in JTT, we
decided to characterize microbial community in JTT by Illumina sequencing. 16S
metagenomic sequencing of Angelica sinensis, which is a JTT component with most
potent immunostimulatory activity, revealed Rahnella aquatilis as the main Gramnegative species. The finding of R. aquatilis in JTT was surprising because LPS produced
by R. aquatilis exhibit endotoxicity, yet JTT does not.
The finding of LPS in JTT opened the possibility that plant metabolites might
modulate the activity of LPS. In order to gain insights into this possible interaction
between LPS and plant metabolites, the second half of my thesis work focused on
chemical and immunological characterization of LPS-plant metabolite mixtures. Since
LPS was known to form nanoparticles in aqueous solution, I hypothesized that plant
metabolites would affect LPS nanoparticle assembly, which, in turn, could modulate
immunostimulatory activity. My thesis work mainly focused on the LPS and BSSG
mixture,

because BSSG

was the most prominent plant metabolite

in the

immunostimulatory fractions purified from JTT. Cell-based assays showed that BSSG
significantly modulated the immunostimulatory activity of LPS. On the other hand,
dynamic light scattering and transmission electron microscope also revealed that BSSG
significantly modulated the nanoscale assembly of LPS. Taken together, these results

vi
suggested that the supramolecular assembly of the BSSG/LPS mixture was a key
determinant of its immunomodulatory activity.
Collectively, this thesis work provided a new molecular basis to understand the
safe and effective immunostimulatory effects of JTT and other immune-boosting
medicinal plants.
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Chapter 1 Juzen-taiho-to as an immunostimulatory herb
1.1. Herbal medicine.
Herbs are the source of many modern medicines used today, such as the antiinflammatory drug aspirin from the willow tree leaves, anticancer drug paclitaxel from
the bark of the pacific yew tree and antimalarial drug quinine from the bark of the
cinchona tree. The use of herbal medicine can be traced back to the Paleolithic age and
documentation of its uses, with the earliest recorded concoctions coming from
Mesopotamia and China, found as early as 2600 BC [1]. The relevance of herbal
medicine and the importance of such studies was recently recognized at the 2015 Nobel
Prize, shared by Dr. Youyou Tu for the discovery of Artemisinin [2] (Figure 1.1). Dr. Tu
and her group found in a 1600-year-old text that sweet wormwood, Artemisia annua, was
utilized to treat malaria. Following the historical clues from the text, she used a scientific
approach to isolate and test the compounds from the known plant. Her search using
Traditional Chinese Medicine (TCM) literature produced an antimalarial drug that is
effective against malaria cases that are resistant to the widely used chloroquine. The
global implications of these discoveries on human health underscore the importance of
herbal medicine as source of modern drugs.
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Figure 1.1. Artemisinin Structure. Isolated from Artemisia annua, this sesquiterpene lactone
targets plasmodium falciparum, the parasite causing malaria. The peroxide bridge is believed to
be important in the mode of action of artemisinin [3].

Herbal medicine has a long tradition in different cultures and for the treatment of
various diseases. The list of countries that use some kind of medicinal herb is extensive,
with multiple plants being used either alone or in combination with other herbs. Although
many countries and cultures have their own plant preparations, none have been able to
establish a more systematic approach to herbal medicine than the Japanese herbal
community [4]. Since TCM was introduced in Japan, it evolved into a more standardized
and controlled system which became known as Kampo medicine. Kampo medicine is
supported and regulated by the Japanese government, therefore it is highly integrated in
the national health care system. In Kampo medicine, the methodology of preparation
requires established ingredients in standardized ratios, making it easier to study various
drugs to assess their mechanisms of function.
Kampo medicine differs from Western medicine in that Western medicine often
works by aiming at one target (e.g receptor)to treat disease, while Kampo medicine is
more holistic and aims to affect multiple targets that are involved in and control
homeostasis. By having multiple targets, Kampo medicines have the ability to affect
physiological systems like immune, endocrine, hematopoietic, and nervous systems as
whole. Out of all 210 herbal formulas found on Kampo medicine, Juzen-Taiho-To (JTT)
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stands out for its versatility and safety. In fact, JTT is an immune boosting herbal
formulation that is used in a range of different therapies and its formulation has also been
shown to protect against Alzheimer’s disease [5].

1.2. Juzen-Taiho-To
JTT was first described in the 12th century by Chinese Pharmacopeia and it is
composed of 10 different herbs, namely Peony Root, Cinnamon Bark, Astragali Radix,
Hoelen, Rehmanniae Radix, Angelica Radix, Ginseng Radix, Cnidium Rhizome,
Glycyrrhizae Radix, and Atractylodes Rhizome (Figure 1.2).

Figure 1.2. Juzen-taiho-to composition. List of the 10 herbal components of JTT which
includes roots, stem, bark and a parasitic fungus.
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Clinical studies have shown the efficacy of JTT for the treatments of numerous
illnesses, such ulcerative colitis, anal fistulas, chronic sinusitis, stomatitis, anemia,
chronic otitis media, and pyorrhea [6]. It also has an important role in cancer treatment
[7-10] (Figure 1.3) where it is commonly used because it improves the patient’s general
condition before and after surgery. In addition, JTT helps prevent the side effects of
chemotherapy and causes overall improvement after radiotherapy treatment [9]. The
positive clinical results and their reproducibility lead to an increase in interest in the
mode of action of JTT. Its effectiveness in alleviating symptoms in different conditions
may be attributed to multiple constituents in the JTT mixture and the complexity of their
interactions with the immune system.
To discern how JTT works, preclinical studies have been performed in-vitro as
well as in animal models. Several studies have shown JTT to induce the proliferation and
differentiation of hematopoietic cells like monocytes and macrophages. [11, 12]. For
example, an in-vitro study has shown that bone marrow cells from mice proliferated in a
dose dependent manner upon JTT treatment [13]. More importantly, animal studies have
shown that JTT has the ability to activate antigen-presenting cells (APC) [7]. In this
study, mice were inoculated with colon cancer cells and JTT fed mice showed less tumor
colonies in the liver and greatly decreased metastasis when compared to untreated
control,. The effects of JTT were greatly reduced when the JTT fed mice were treated
with 2-chloroadenosine, known to destroy macrophages. The effects of JTT were also
reduced on T-cell deficient mice [7, 12]. (Figure 1.3 and Figure 1.5). This studies
confirmed the role of JTT in macrophage activation. This is important because APC cells
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are part of the first layer of protection of the immune system, the innate immune
response.

Figure 1.3. JTT activity in mice. JTT ability to activate macrophages was shown by testing the
activity of JTT prior and after the addition of 2-chloroadenosine to the mouse diet. 2choloroadenosine is used to deplete macrophage population. JTT had no effect in decreasing
metastasis on mice with 2-chloroadenosine depleted macrophage population. This study
suggested the link between JTT and macrophage activation [7, 12].

1.3. Objective, central hypothesis and significance
Although the medicinal effects of JTT are well documented, the recipe
standardized and some of its cellular targets known, understanding the mechanism of
action of JTT is complicated because different batches of JTT may have different
therapeutic efficiency. Therapeutic effects of individual herbs depend on various factors,
such as time of harvest, soil composition, and local climate where the herbs were grown.
This is a significant issue for clinical use because the same plants can have a variable
therapeutic efficacy depending on the variations in these conditions. Hence standardizing
the ratio of herbs used in the mixture may not be enough to ensure consistent clinical
effectiveness.
Another important issue is that despite JTT being a medicine with wellestablished beneficial effects, it shows adverse interactions with other drugs. One such
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example is the interaction of JTT with the anticancer drug Tamoxifen. Tamoxifen works
by inhibiting the growth of breast cancer cells by lowering estrogen levels in estrogen
positive breast cancer patients. The effect of tamoxifen can be antagonized by the
estrogenic activity of JTT [9].
Studying the active compounds of JTT can be challenging due to the complexity
of the concoction. It is recognized that the efficacy of JTT, as well as of other Kampo
formulations, cannot be easily explained by the sole pharmacological activity of any one
of the active factors, as these factors may have an effect on multiple systems. However, a
deeper understanding of the herbs, including origin and history of the different
components and how they function in the mixture independently and with each other is
needed to optimize the therapeutical performance of the herbal medicine and to identify
and minimize the undesirable cross-interaction between JTT and other treatments.
Specifically, the knowledge gap that needs to be filled centers on the molecular activity
of the herbal mixture.
A few preclinical studies have started to define the cellular targets of the drug, but
in order to understand how JTT works, the molecular mechanism of immunostimulation
needs to be deciphered (Figure 1.4). Mechanistic understanding is necessary because this
could direct the creation of a safer and more standardized products and potentially
simplify and optimize medicine production by avoiding unnecessary and undesired
constituents. Thus, standardization is critical for properly exploiting the many therapeutic
benefits of JTT.
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Figure 1.4. Knowledge gap in JTT targets and function. Clinical studies have shown the
effects of JTT in cancer treatment, and immune stimulation. Preclinical studies gave a better
understanding of JTT by determining the cellular targets of the drug. Molecular targets and
molecular understanding of JTT are, however, still limited. These include active components,
component interactions and specific cellular targets. This knowledge would greatly improve the
safety and efficacy of the medicine.

The first important step in understanding JTT mechanism is identifying the active
factors that make JTT an immunostimulant. Previous studies suggested carbohydrates,
such pectins, as the possible immunostimulants in JTT [6]. These carbohydrates rich
extracts were not fully purified, leaving the door open to other immunoactive JTT
components. We propose that more lipophilic immunoactive compounds may have been
undetected in earlier extracts, and chose to revisit the mixture.
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1.4. Current work on understanding JTT mechanism.
Earlier preclinical experiments, suggested that the activity of JTT is caused by
activation of Antigen Presenting Cells (APCs) [6, 7, 12]. The APCs in the innate immune
system recognize pathogens’ unique surface molecules, which are called pathogen
associated molecular pattern (PAMP). PAMPs represent the non-self molecules, such as
carbohydrates, peptidoglycans, and lipopeptides found on the surface of pathogens such
as fungi, viruses and bacteria. One of the most well-known PAMPs is bacterial
lipopolysaccharide (LPS). LPS is found on the bacteria cell membrane and is
recognized by the Toll-like Receptor complex CD14/TLR4/MD2 on APCs. In addition,
NOD-like receptors (NLR) are able to identify intracellular LPS. Other TLRs that
recognize various other pathogens’ molecules, such as lipids and oligonucleotides can
also be present on APCs.
PAMPs recognition by the TLRs activates APC immunoactivity through the NFĸB pathway. For more details see Figure 1.5.
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Clearance
of
pathogens

Figure 1.5. Recognition of pathogens by Antigen presenting cells. a. Pattern Recognition
Receptors (PRRs) are able to physically recognize elements found on the pathogen’s surface
(PAMPs). This recognition leads to the activation of the APC through NF-ĸB pathway and
release of cytokines. b. Upon activation, APC become phagocytic and clear pathogens more
efficiently. They also present T cells with fragments of the pathogens through the Major
Histocompatibility Complex (MHC), which leads to the activation of the adaptive immune
response.

For our study, we decided against the use of animal models because of the
complexity of the herbal mixture and reproducibility issues mentioned in the previous
section. As the preclinical experiments determined that the activity of JTT is due to APCs
activation we chose to test the activity of JTT on a cell-based assay. The use of primary
cells (dendritic cells, macrophages and monocytes) was not feasible for our mechanistic
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studies due to the difficulty in isolating and growing them in the lab. We, thus, focused
on cancerous cells as there are multiple lines that are easily grown in the lab and sensitive
to immunostimulating factors. Notwithstanding their cancerous origin, THP-1 cells
response to JTT correlates very well with primary cells [14]. Dr. Hasson, a former
member of the lab, tested the immune response in various tumor lines. Based on his
results THP-1 cell line was chosen to test for JTT immunological effects. THP-1 cells are
human monocytic leukemia cells, and they are easily grown in the lab. They can be easily
differentiated into dendritic-like cells and macrophage-like cells, and they respond to a
variety of immunostimulating factors.
The next step was to find a reliable marker to test for immunostimulation. For this
purpose, we performed a genomic screening of THP-1 cells after treatment with JTT
against vehicle control. In this procedure, gene-chip oligonucleotide array in tandem with
qRT-PCR revealed multiple genes that were downstream of nuclear factor kappa B (NFkB) pathway and were differentially regulated upon immunostimulation. Some of these
genes are: ICAM-1, IL-1B, TNF-α [15, 16]. ICAM-1 was chosen as the most reliable
marker for JTT activity [14, 17].

Table 1.1. Structure of glycolipids and phytosterols found on JTT

Structure

Name
monostearin
stearic acid
monobehenine
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monopalmitin
palmitic acid

-glucocerebrosides (4-trans, 8cis/trans)

stigmateryl -D-glucoside

-sitosteryl -D-glucoside
(BSSG)

monogalactosyldiacylglycerol
(MGDG)

digalactosyldiacylglycerol
(DGDG)

In our original foray into isolating and characterizing JTT active factors and
function, we succeeded in enriching the APC stimulatory fraction. Analysis of the
enriched fraction by LC-MS showed large amounts of phytosterols, a cholesterol like
plant compounds, and several glycolipids. The compounds found were: monostearin,
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stearic acid, monobehenine, monopalmitin, palmitic acid, -glucocerebrosides (4-trans,
8-cis/trans), stigmateryl -D-glucoside, and -sitosteryl -D-glucoside (BSSG). (Table
1.1)
The characterization of the isolated constituents showed limited activity either
individually or in combination. β-glucocerebrosides had modest activity when compared
to JTT, while all the other glycolipids had either marginal or no activity [14, 18].
As our efforts were successful in isolating important components of JTT, but not
equally successful in replicating JTT activity and as we were still unable to identify the
elusive active compound from the mixture, we surmised that the isolation techniques
used to separate and identify the active compound were not sensitive enough.
Considering the complexity of the sample and the heterogeneity of the JTT mixture it was
possible that the concentration of the unknown stimulant was low, a possibility that
intriguingly hinted at the potency of the molecule itself.
The isolation and analysis of the compounds in JTT, however, provided us with
valuable methods and insight form future studies. We inferred that based on the chemical
structure and polarity of the molecules found on the active fraction, the missing factor
most likely had a similar structure to glycolipids. It was also concluded that the active
compound was extremely potent as we were able to observe and quantify its effects in
our cell assay even though not enough of it was obtained through the enrichment to be
seen by LC-MS analysis. This information lead to new approach to identify this unknown
glycolipid.
This work will touch on the study of immunoactive JTT components. Chapter 2
discusses how the active compound in JTT was finally identified, and how it was found
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to originate from an unexpected source, bacteria. Chapter 3 discusses how the bacteria at
the origin of the active compound was identified. Chapter 4 discusses the interaction of
our active compound with the other components from JTT, how this interaction can
modulate the glycolipid immune activity, and how this discovery is driving the
understanding of the supramolecular assembly of glycolipids. Finally, Chapter 5 would
give an idea on the future directions that this study coud take.
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Chapter 2 Identification of Lipid A, key glycolipid in JTT
2.1. Introduction
Juzen-Taiho-to, a popular herbal formulation in Japan, has documented immuneboosting effects [1-6]. Our lab recognized JTT as a potential source of immuneactivating
compounds, and efforts were made to isolate these compounds. By means of
fractionation, chromatographic methods and chemical analysis, our group discovered that
β-sitosteryl β-D-glucoside (BSSG) and stigmateryl β-D-glucoside were the most
prevalent components in the active fraction (see Table 1.1 in Chapter 1). Other
compounds uncovered as part of the active fraction [7, 8] were: monostearin, stearic acid,
monobehenine, monopalmitin, palmitic acid, β-glucocerebrosides (8-cis and 8-trans
isomers).

During

fractionation,

the

mixture

of

these

compounds

showed

immunostimulatory activity on THP-1 cells. However, when the purified glycolipids
were tested individually, most of them had marginal or no measurable activity. This
intriguing finding opened the possibility of a missing factor yet to be discovered in JTT.
Other groups have also sought out the active compounds and some progresses
have been made. For example, Yamada et al. endeavored to isolate the active factors by
fractionating the methanol extract of JTT and subsequently followed the fractions’
activity by monitoring lymphocyte proliferation. The study showed the presence of
palmitic acid, stearic acid, oleic acid, and linolenic acid [5] in the active fraction. sitosterol was also found to be one of the components in the active proliferating fraction.
For the activity study, oleic acid and linoleic acid showed twice the proliferation
compared to the control. Palmitic acid and stearic acid showed moderate proliferation. -

16
sitosterol caused no proliferation. Although some of these lipids showed activity, the
authors did not specify if the proliferation was comparable to whole JTT’s.
Even though our initial search for the main active components in JTT was
unsuccessful, it left us with some important clues [8]. We learned that the
immunostimulant candidate would most likely have a glycolipid framework. Glycolipids
are amphipathic molecules, with a polar head and non-polar lipid tale, therefore the
candidate immostimulant should have similar polarity as glycolipids. Furthermore, the
candidate factor must be very potent because it had immunostimulatory effect even when
diluted to an extent that there was lack of clear of signals from this unknown molecule on
HPLC as well as MS. With this in mind, we hypothesized that the mysterious immune
stimulating factor would be lipid A (LA), a bacterial product obtained from the
hydrolysis of lipopolysaccharide (LPS). Our hypothesis was supported by the LPS-like
activity of JTT [1, 3, 9]. Both JTT and LPS induce similar gene expression profiles on
macrophages [8, 10]. LPS is a large glycolipid that covers the outer surface of gramnegative bacteria. LA is the inner glycolipid moiety responsible for the well-known
immunostimulatory activity of LPS (Figure 2.1) [11-14]. The hypothesis was based on
the fact that plants harbor a wide variety of gram-negative phytobacteria, which produce
structurally diverse LA variants. LA is a known bacterial product, and JTT components
are mostly roots, making it very likely that phytobacteria could be present as part of the
herbal mixture. Even though there are multiple pathogenic bacteria that attack and harm
the plants, there are others that are very important for its health and growth.
Rhizobacteria for example are able to enhance the growth of the plant by helping the
plant absorb substrates from the soil with the help of siderophores and affecting soil pH
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[15-18]. Plants are known to nurture bacteria that can fix nitrogen [19, 20] and protect
them from other harmful plant pathogens [21].
Our hypothesis was also supported by the studies on immune-boosting herb
Echinacea. Studies by Pasco and co-workers showed that bacteria load correlated to the
macrophage activity of Echinacea [22]. Further studies also showed that the activity of
Echinacea decreased when exposed to Polymyxin B (pmxB), a LA binding peptide [23,
24]. Taken together, the data from our lab and from others strongly supported the idea
that LA was the cause of the immune-boosting activity of JTT.
The first step to test our hypothesis was to test for the presence of bacterial LPS in
the sample; hence, we subjected JTT to chromogenic limulus amebocyte lysate (LAL)
assay [25]. LAL assay detects endotoxic LPSs of human pathogenic gram-negative
bacteria, which trigger potent and toxic pro-inflammatory responses. LAL assay,
however, does not detect many structural variants of LPS, including non-endotoxic LPS
produced by phytobacteria. It was previously found that the endotoxicity of JTT is lower
than the detection limit for the assay [26]. The LAL assay confirmed that endotoxins
level could not account for the potent immunostimulatory activity of JTT. As such, we
concluded that the activity of JTT was not due to common bacterial contamination (such
as, E. coli). Instead, the presence of immunostimulatory phytobacteria in JTT was
confirmed.
LA is obtained from the hydrolysis of LPS under acidic conditions. Besides LA,
LPS consists of a core polysaccharide and the O-antigen repeat. The O-antigen repeat is
the most variable segment of LPS, and in association with the core polysaccharide it
gives LPS its hydrophilic characteristic. The LA segment serves to anchor LPS in the
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bacterial membrane due to its hydrophobicity. The LA backbone consist of two
glucosamine molecules, two to one phosphate groups and 4 to 6 acyl chains, 6 being the
most common (Figure 2.1a). The biosynthesis of the LA fragment has been extensively
studied [27-29], and each bacterium can have multiple LA isoforms at any given time.
LA structure is also dynamic; it can change in response to environment stimuli. One
example is LA found in Yersenia pestis, the bacteria that causes bubonic plague. Y. pestis
is able to detect changes in temperature, adapting and modifying its LA. This is important
because Y. pestis uses fleas as a vector for infection, and the body temperature of fleas is
< 30ºC. At this temperature Y. pestis LA is hexaacylated, and is unrecognized by the
flea’s immune system (Figure 2.1b). In humans, Y. pestis is able to avoid recognition of
the innate immune system by partially deacetylating LA. By becoming tetraacylated at
37ºC (human body temperature) Y. pestis LA is not only not recognized by macrophages,
but it becomes antagonistic to LA receptors (TLR4), preventing phagocytosis and
suppressing inflammation [30] (Figure 2.1c). There are other examples of bacteria that
modify their LA structure to evade the innate immune cells, and they achieve it by
substituting the phosphate groups and avoiding the presence of cationic peptides [31, 32].
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Figure 2.1. Structures of Lipopolysaccharide (LPS) and Lipid A (LA). a. Structural scheme
of LPS from E. coli K12 [33]. Structure of LPS is divide into 3 parts: O-Antigen repeat, Core
polysaccharide and Lipid A. The monosaccharides shown in the structure are 3-deoxy-D-mannooct-2-ulosonic acid (Kdo); L-gycero-D-manno-heptose (Hep); Glucose (Glu); Galactose (Gal);
Ethanolamine (Etn); and Phosphate group (P) b. LA structure of Y. pestis from the wild type,
after growing at 20-28ºC. Hexaacylated LA, in which there are two 4-amino-4-deoxy-L-arabinose
(Ara4N) added to the phosphate groups [30, 34, 35] c. Tetraacylated LA of Y. pestis from the
wild type, after growing at 37ºC.

In humans LPS is detected by APCs, such as monocytes, macrophages as well as
dendritic cells. APCs physically recognize bacteria by identifying pathogen-associated
molecular patterns (PAMPs) on the pathogen’s exterior. To achieve this, phagocytic cells
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display pattern recognition receptors (PRRs) that are specific for PAMPs. The most
famous example of a PAMP is the LPS found on gram-negative bacteria. LPS is
recognized by monocytes/macrophages by the Toll like receptor 4 (TLR4) in conjunction
with MD-2, CD14 and LPS Binding Protein (LBP) [36-39] (Figure 2.2). LPS recognition
leads to inflammation and T-cell activation [40-43]. In the case of TLR4 and LPS, the
interaction triggers a cascade of signals leading to the downstream activation of NF-B
(nuclear factor kappa-light-chain-enhancer of activated B cells) [44] and cytokine release.
Cytokines are the chemicals in charge of communication between the innate and acquired
immune response. LPS can also mediate NF-B activation through TLR2 receptors. LPS
binding can trigger the release of pro-inflammatory cytokines, eicosanoids and nitric
oxide. This causes inflammation that can lead in extreme cases of sepsis [28, 45]. LPS
identification through TLR is not the only way LPS is detected. There is also TLR4
independent recognition, mediated by the non-canonical inflammasome pathway, which
functions by detecting LPS intracellularly [46, 47]. Non-canonical inflammasome is
mediated by caspase-11, instead of caspase-1, associated to TLR4.
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Figure 2.2. TLR4 activation by LPS. LPS/LA is first detected by LBP (not shown) which
moves it to CD14 and MD-2. This triggers the activation of TLR4 through its interaction with
MD-2/LPS and CD14 which causes the dimerization on TLR4. Once TLR4 is dimerized, the
complex intracellular domain interacts with the TRAM/TRIF complex as well as the
TIRAP/MyD88 complex. The TRAM/TRIF complex binding to the receptor causes the nuclear
factor IRF3 to travel into the nucleus and promote the expression of type I interferons. Interferons
are used for cell to cell communication; in this case it leading to the activation of T-cells and Bcells. When TIRAP/MyD88 binds to the receptor, nuclear factor NF-B gets activated which in
turn leads to the transcription of proinflammatory cytokines and chemokines. TLR4 can also be
activated while endocytosed. This event leads to the activation of IRF3 only.

Macrophages and dendritic cell reply to LPS by coordinating the innate immune
response as well as the adaptive immune response. LPS is capable of triggering two
distinct activation pathways by TLR4: MyD88 mediated pathway, and TRIF mediated
pathway (Figure 2.2). MyD88 mediated pathway is able to activate the NF-B
downstream pathway in which pro-inflammatory cytokines are released, namely
Interleukin-6 (IL-6) and Tumor Necrosis Factor alpha (TNF-) to name a few. These
cytokines recruit leukocytes towards the area of infection, leading to swelling and
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increasing blood flow in the affected area [12]. On the other hand, LPS can also trigger
TRIF mediated pathway, which is in charge of stimulating the release of type I
interferons, Interferon alpha (INF-) and Interferon beta (INF-). These interferons are
the molecules responsible for cell-to-cell communication and activation of dendritic cells,
T cells and B cells in response to the presence of a pathogen [48]. Overall, the interplay
between MyD88 pathway and TRIF pathway is what determines the toxicity level of
LPS.
In this chapter, I will describe how the presence of LA in JTT was tested by the
use of LPS removing gel (pmxB). How LA was enriched in the JTT sample and how of a
novel immunoactive LA-like molecule was identified.

2.2. Results
2.2.1. Polymyxin B affinity resin depletes the immunostimulatory activity of JTT
In order to test if LA contributes to the immunostimulatory activity of JTT, we
first treated the herbal formulation with polymyxin B (pmxB) resin, in which pmxB is
immobilized on agarose [49]. PmxB is a cationic peptide that binds tightly to the LA
moiety of LPS through a hydrophobic pocket in which the lipophilic acyl chains can bind
to, while nitrogen stabilize the negative phosphate charges. A decrease in
immunostimulatory activity from pmxB treatment would indicate LA is present in the
JTT sample. Three different samples, namely, untreated JTT (DMSO), mock treated JTT
(JTT sample that had been passed through streptavidin affinity resin), and pmxB-treated
JTT, were subjected to a cell-based assay of immunostimulation. In this assay, qRT-PCR
is employed to quantify the mRNA induction of intercellular adhesion molecule 1
(ICAM-1), our chosen biomarker of immunostimulation, in THP-1 cells (a human
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monocytic cell line). The results showed that the induction of ICAM-1 was lowered from
29 to 12-fold upon pmxB treatment of JTT (Figure 2.3b). The observed result was
consistent with the hypothesis that LPS/LA contribute to the immunostimulatory activity
of

JTT,

although

it

remained

possible

that

the

pmxB-treatment

removed

immunostimulatory factors other than LPS/LA. As it is possible that pmxB binds other
positively charged phospholipids, we decided to pursue a different approach.

a.

b.

Figure 2.3. PmxB effects on JTT immunostimulatory activity. a. The structure of polymyxin
B (pmxB) resin, a cyclic peptide that is capable of binding LPS/LA by ionic and hydrophobic
interactions. b. Activity of JTT upon treatment with pmxB resin. When JTT was treated with
streptavidin affinity resin (JTT Mock), there was no change in activity. There is almost a 17-fold
difference in activity between sample with pmxB treatment and untreated sample. THP-1 cells
were treated for 4h, with DMSO, negative control; JTT (100 µg/mL); JTT Mock (20 µg/mL),
resin negative control; and JTT PmxB (20 µg/mL). Cells were lysed and RNA was purified using
RNA kit. RNA was reverse transcribed and diluted. The samples were then analyzed by qRTPCR using ICAM-1 probe. Statistical analysis using student’s t-test showed correlation with p <
0.01

2.2.2. Enrichment of LA from JTT.
Although the loss of activity in JTT sample after pmxB treatment suggested that
LPS/LA was present in the herbal mixture. In order to find more evidence for the
presence of LA, the next step was to enrich LA by using a modified protocol for bacterial
LA extraction [50] (Figure 2.4a). First, JTT was boiled in water and filtered to remove
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any insoluble material. The aqueous solution was then cooled, and washed with organic
solvents to delipidate the sample. LPS would stay in the aqueous layer because of the
large hydrophilic polysaccharide moiety. The water extract was then acidified (pH 4.5)
and heated to hydrolyze LPS. The resulting LA, which is much more hydrophobic than
LPS, was then extracted to the organic layer of the CHCl3/MeOH/H2O 2:2:1.8 (v/v/v/v)
mixture. To further purify the LA sample, preparatory TLC (CHCl3/MeOH/H2O/NH4OH,
40:25:4:2 (v/v/v/v)) was performed. The resulting preparatory TLC fractions exhibited
the Rf values that were consistent with the polarity of typical LAs (Figure 2.4b)

a.

b.

Figure 2.4. Purification scheme for Lipid A enrichment. a. The first delipidation step removes
most lipids while LPSs remain in the aqueous phase. The crude LPSs were transformed to LA by
acid hydrolysis. LA was enriched in the organic layer. b. TLC profiles of LA-like factors. In the
condition used (CHCl3/MeOH/H2O/NH4OH, 40:25:4:2, v/v/v/v), LAs typically show up in the Rf
region highlighted by the red bar (Rf 0.2–0.6).

2.2.3. Activity of enriched LA from JTT.
The immunostimulatory activity of the obtained fractions was tested by the
ICAM-1 assay. By comparing the activity of the samples to the DMSO control, we
observed the highest activity on fractions 3, which coincided with the Rf consistent with
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the presence of LA (Figure 2.5). Fraction 1 had the lowest activity out of all samples.
Fractions 2, 4 and 5a were active, with the activity likely coming from LA content.
Overall, these results strongly suggested that LA was enriched and present in at least 4
fractions.

Figure 2.5. Immunostimulation by LA-like factors. ICAM-1 qRT-PCR of LA enriched
fractions of JTT in THP-1 monocytes. THP-1 cells were treated with 5 different fractions (Fr.1 to
Fr.5) of enriched LA from JTT. All fractions were tested and the most active fraction was found
to be Fr.3. THP-1 cells were treated with DMSO; JTT (100 µg/ mL); LPS (100 ng/mL); LA-like
factors (5 µg/mL). The relative quantification (RQ) values were used to compare the samples
against DMSO control. RQ is the fold-change ratio of samples against DMSO control. All
samples were run on triplicates under said experimental conditions.

2.2.4. Characterization of active LA fraction by Mass Spectrometry.
To determine if the LA was indeed found in these fractions, we used mass
spectrometry (MS) to check for the expected molecular mass. We found m/z for single
charged and double charged in positive mode that had a molecular formula consistent
with the backbone of monophosphorilated LA, molecular formulas of C 83H145N2O23P
(Mass: 1568.9976) and C120H217N4O38P (Mass: 2353.4908) (Figure 2.6). More
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importantly, the m/z was not a perfect match for known LA structures, making it possible
for a novel LA variant to be present in the herbal mixture.

a.

b.

Figure 2.6. Mass spectroscopy of JTT fractions. HRESIMS analysis of LA-like factors
(Fraction 3 in Figure 2.5). Ions corresponding to two LA-like factors (Cpd 1 and Cpd 2) were
observed in Fraction 3. Table provides possible LA species based on M/Z ratio matching LA
structure.

2.3. Discussion
Up to this point immune modulation of JTT has been attributed to compounds
originating directly from the herbs, without considering the bacteria present in JTT. As
JTT consists of 10 herbs, it is likely that total bacteria load is very complex. With this in
mind, it becomes clear why the isolation of the immunomodulating factor was quite
complicated. First of all, only a fraction of the total plant biomass can be attributed to
bacteria; and even a smaller fraction can be attributed to LPS-containing gram-negative
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bacteria. The amount of expected LPS/LA therefore would be minimal. Thus, it was no
surprise that LA was not easily detected during HPLC profiling as well as MS.
Collectively our results strongly indicate LPS/LA is the main immune-stimulatory
component in JTT. We were able to deplete the activity of JTT by using pmxB resin,
suggesting LPS/LA was a key component in the activity of the herbal concoction. We
were also able to enriched LA from JTT, obtaining fractions that possessed LA-like
immunoactivity. Out of all this fraction, we confirmed the presence of LA in the most
active one, fraction 3.
Our group’s results have important implications in experiments dealing with the
purification of glycolipids and polysaccharides from plants. The potency of LA and LPS
can be an issue while looking for immunoactive compounds. Incomplete elimination of
LPS/LA could falsely make other compounds look like they have immune stimulating
properties. In our case, during our JTT purification the isolated glycolipids and
phytosterols were suspected to be immunostimulant, even though the minimal amounts of
LA in the active fraction was the actual cause of most of the activity. Other groups could
have had the same problem. For example, other group studying JTT identified
polysaccharides with mitogenic activity [5, 51]. The extraction of this polysaccharide was
done by hot water extraction, anion exchange column, and eluting through a hydrophobic
resin. Based on the extraction method they used, one can conclude that there is possibility
of LA getting included in the sample. This opens the possibility that, without knowing
about bacteria contribution, minute amounts of LPS were the actual cause of the observed
polysaccharide activity in other extractions as well.
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Studies on Yamoa™ (the ground bark of Funtumia elastica) [52] and the tropical
fruit Acai [53] (Euterpe olearacea) suggest that the immune-boosting activity of those
plants is due solely to complex carbohydrates, however our data suggest that there may
be more to this story. For example, the polysaccharides found in Yamoa and Acai had the
same activity profile as LPS. In both cases, researchers tried to eliminate any possibility
of LPS by eluting the samples through a column of endotoxin-removal gel. The removal
of LPS, however, may be partial due to the fact that LPS forms aggregates in water,
hiding the LA fragment from the gel. We suggest that this might be similar situation as
with the previously mentioned polysaccharides from JTT. The same way LPS was found
to be important in the activity of JTT, and the activity of echinacea [22, 24]. These
findings open up exciting possibilities for the discovery of novel LAs in JTT and other
medical herbs and for the study of herbs immunostimulatory activity.
LA’s unique structure made it difficult to isolate ample amounts of the substance.
During our JTT study, we were able nevertheless to secure enough of the material from
the most active fraction, Fraction 3 (Figure 2.5) to perform LC/MS. The MS spectra was
our first direct confirmation that LA was present in JTT (Figure 2.6). Even more
interesting, the structure of the LA molecule we isolated and began to characterize does
not match any of the known structures found on public database, suggesting we recovered
novel immunostimulating compounds. From the proposed molecular formula obtained
from fraction 3 (monophosphorilated LA), one can infer the structures of the LAs
observed in the other fractions. Fraction 2 could possibly have longer acyl chains.
Fraction 4 and 5a, could be diphosphorilated LAs or even partial deacylated [50].
Deacylation would be reasonable assumption, because tetraacylated LA is less active than
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hexaacylated [30]. The fact that most fractions were active suggest that there might be
many more novel LAs to be found in JTT, which in the future we might be able to
characterize. Once identified, these LAs could lead to the creation of an immunoadjuvant
library of LAs.
Overall, enrichment of LA showed that LA-like factors were present in JTT. The
fact that multiple factors were present indicates the possibility of JTT contains a wide
variety of LPSs coming from the same and/or multiple bacteria. Therefore, we can
surmise that the odds of isolating LA from JTT for further characterization are minimal.
We resolved that one way to deal with the complexity of JTT and home in on the
identification of LA of interest was by looking at the individual herbal components and
investigate the bacteria present in them by metagenomic analysis. The results of this
analysis will be discussed in Chapter 3.

2.4. Materials and Methods
Materials. Organic solvents were HPLC grade and were purchased either from
VWR or Fisher Scientific. Juzen-taiho-to (JTT) formulation was purchased from TCM
Zone/Honso Pharmaceutical Co. (Nagoya, Japan) as a dried water extract. All reagents
and supplies for qRT-PCR were purchased from Life Technologies (Grand Island, NY).
Unless specified otherwise, all other chemicals and reagents were obtained from Fisher
Scientific and VWR and used without further purification.
Endotoxin Removal using Detoxi-Gel (polymyxin-B affinity resin). 10 mg of
JTT powder was dissolved in 2 ml of Millipore water to prepare a stock solution of
concentration 5 mg/mL. Equal amounts (0.5 mL) of Streptavidin Agarose Resin (Thermo
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Scientific, Prod. # 20349) and Detoxi-Gel TM Endotoxin Removing Resin (Thermo
Scientific, Prod. # 20339) were taken in separate Eppendorf tubes. The tubes were
centrifuged at >10,000 rpm for 1 minute to remove preservative solution from the gels.
The gels were washed 3 times by adding 700 μL of Millipore water and centrifuging at
>10,000 rpm for 1 minute to remove residual preservative solutions from the gels. 0.5 ml
( ~2.5 mg) of JTT stock solution was added to Avidin and Detoxi gels. 0.5 ml (~2.5 mg)
of JTT stock solution was taken in a fresh Eppendorf tube to serve as a positive control
for the experiment. 0.5 ml of Millipore water was used as a negative control. The
Eppendorf tubes were placed in a tube rotator overnight at 4°C. The tubes were
centrifuged at >10,000 rpm for 1 minute the following day. 400 μL (~2 mg) of the
supernatants of each of the samples was filtered through a 5 ml syringe filter into preweighed eppendorf tubes. The tubes were dried in the Eppendorf Vacufuge, and weighed
again. The samples were dissolved in DMSO to achieve a concentration of 0.02 μg/μL
for THP-1 cell treatment. Final concentration of samples in media used for treatment was
0.1 μg/mL.
Enrichment of the LA-like factors from JTT. JTT (10 g) was boiled in
deionized water (100 mL) for 90 minutes. Insoluble materials were removed by hot
vacuum filtration. Once cooled, the aqueous solution was placed into a separatory funnel
with 200 mL of CHCl3/MeOH (1:1 (v/v)). The entire mixture was shaken vigorously and
then left to stand uncapped for about 20 minutes to allow separation of the organic (org)
and aq layers. The top hydrophilic layer was mixed with 20x acetate buffer to obtain a
solution in 1x acetate buffer (pH 4.5). The solution was boiled in an Erlenmeyer flask for
1 h. and left to cool. The hydrolyzed sample was transferred into a separatory funnel. The
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LA-like factors were extracted with CHCl3/MeOH (1:1 (v/v)) (100 mL × 2). The extract
was placed in a round bottomed flask with 100 mL of 1-propanol and dried in vacuo.
Cell culture of THP-1 monocytes. THP-1 cells were purchased from American
Type Culture Collection (ATCC). Cells were propagated in RPMI-1640 media containing
25 mM HEPES and L-glutamine (HyClone), 10%(v/v) fetal bovine serum (Fisher),
1%(v/v) penicillin, streptomycin and amphotericin B mixture (VWR) and 0.005 mM βmercaptoethanol. Cells were maintained in a 37 °C humidified 5% CO 2 incubator.
ICAM-1 qRT-PCR. THP-1 cells were split on the day before the treatment (0.25
× 106 cells/well of a 12-well plate). After 24 h, cells were treated with samples or DMSO
vehicle control for 4 hours in a 37 °C humidified 5% CO 2 incubator. RNA purification,
cDNA synthesis, and qRT-PCR on an Applied Biosystems 7500 Real-Time PCR system
were carried out as described previously.[8, 54] In the qRT-PCR experiment, preoptimized assay for ICAM-1 (Life Technologies Assay Id: Hs00277001_m1) and
GAPDH endogenous control (Life Technologies Catalog Number: 4352934E) were used.
The ∆∆CT method was employed to quantify the differential expression of ICAM-1 [54].
The raw data were first normalized by the endogenous control (GAPDH) for individual
samples. Then the relative quantification (RQ) values, i.e. the fold-change ratios, were
obtained by comparing the normalized data against the DMSO vehicle control.
Fractionation of the LA-like factors by preparatory TLC. Prior to use, TLC
plates were washed with methanol in a developing chamber and allowed to dry overnight.
The sample was dissolved in a small amount of CH 2Cl2/MeOH (1:1) and spotted on the
plates. Plates were developed in CHCl3/MeOH/H2O/NH4OH (40:25:4:2 (v/v/v/v)).
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Visible bands and the areas in between were scraped off and extracted with
CH2Cl2/MeOH (1:1).
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Chapter 3 Bacteria Identification in Angelica Sinensis
3.1. Introduction
Bacteria was suspected as the cause of JTT’s immune modulating activity. Upon
our results, we deemed necessary to determine what species of bacteria, if any, could be
identified and shown to be present and enriched in the herbal mixture. Enrichment of
specific kind of bacteria has been shown in the case of the rhizosphere of switchgrass [1]
and Arabidopsis thaliana [2, 3]. Based on our previous data showing the lack of JTT LA
endotoxicity, we hypothesized that the LAs from these bacteria would be able to
stimulate the immune response without triggering inflammation.
While exploring and deciding on what better method to analyze the JTT microbial
composition, we concluded that attempting to analyze the whole bacteria make-up from
JTT was not practical due to their enormous diversity. As stated, JTT is composed of 10
herbs, 6 of them roots (Peony radix, Astragali radix, Rehmanniae radix, Angelica
sinensis, Ginseng radix, Glycyrrhizae), 1 bark (Cinnamon bark), 1 fungus (Hoelen) and 2
stems (Cnidium rhizome, and Atractylodes rhizome). Hence, the bacteria component of
JTT would most likely be very complex to analyze due to the expected diversity. It was
also conceivable that JTT would contain a minuscule amount of the DNA needed for
sequencing, mainly because the commercial samples are sold as water extract. Taking
these problems into account, we simplified the study by looking at individual components
of JTT. As rhizobia bacteria are the most common bacteria found in plants, and they are
associated with roots, that is where our investigation focused.
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Our lab was able to

determine that 3 herbs showed considerable activity

individually (Figure 3.1): Angelica sinensis, Peony Root, and Cinnamon Bark [4].

Figure 3.1. Activities of Individual JTT components. (Takaoka [5]). Activity of 10 JTT
components were analyzed using THP-1 cells. The samples were prepared by resuspending the
water extract of the herbs in DMSO. Cells were treated with 100 μg/mL of DMSO solution.
DMSO was used as a negative control.

Based on the activity analysis of the herbs, LA was most likely present in
Angelica sinensis and Peony Root, because of the higher possibility of endophyte growth.
Cinnamon Bark as well showed immunomodulating activity, so it was considered for LA
enrichment.
A. sinensis, also known as Dong Quai or “female gingseng”, grows in the
mountains of Japan, China, and Korea. It is used in traditional Chinese medicine to treat
osteoarthrosis [6-8], inflammation [9-12] and mild anemia [13] to mention a few
conditions. Studies suggest that A. sinensis also promotes angiogenesis and osteogenesis
[6, 7, 14-16]., and more importantly, it possesses immunomodulating activity [17-19] The
second plant with the highest immune activity, Paeonia lactiflora (Peony root), is native
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of central and eastern Asia and it is mainly used to diminish allergic reactions [20, 21].
The last herb was Cinnamomum cassia (Cinnamon bark). It is found all over the world,
and it’s a very popular spice as well as a natural treatment for diabetes mellitus [22-24].
Importantly for us, extensive studies have shown that Cinnamon is able to modulate the
innate immune system [22-24]. Between the three herbs, we decided to start
metagenomic analysis with A. sinensis since it showed the highest activity.
The investigation of the bacterial community in JTT was done using next
generation sequencing (NGS).
Bacteria communities in plants can be studied by 16S ribosomal RNA gene
(rDNA) analysis. 16S rDNA amplicon sequencing can be done quickly and inexpensively
through Next Generation Sequencing (NGS) technology. In addition, numerous studies
have used NGS for the identification of microorganisms in human’s gut, soil and plants.
NGS has made it possible to sequence multiple fragments of DNA at the same time and it
allows scientists to look at DNA from multiple sources, by allowing parallel sequencing
of DNA. Multiple studies examining microorganism population have taken advantage of
this simple sequencing method. Thanks to NGS, the ability to sequence has grown
exponentially, becoming readily accessible [25]. There are different types of NGS,
pyrosequencing being the most popular initially due to its high consistency to the original
sequence, however the process was slow and expensive due to the need for multiple
enzymes. We chose to use Illumina sequencing which is mostly used today for its robust
and inexpensive sequencing.
One of the key elements for 16S rRNA gene sequencing is the primer design.
Primers used in this method need to be specific and to allow to discriminate between
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similar genes (e.g. 16S from bacteria versus 18S in humans). 16S rDNA (Figure 3.2) is
found in bacteria and archaea, and it is characterized by having regions of high variability
that are unique to each species and it is considered as a “barcode” that can be used to
identify specific bacteria. Primers are designed to target the 9 variable regions that are
used for phylogenetic classification.

Figure 3.2. 16S rRNA gene scheme. Bacteria have 9 variable regions (blue) which serve as a
barcode for the identification of bacteria. Amplification of those variable regions using qRTPCR
is used for sequencing. The typical size of 16S rDNA is ~1500bp.

3.2. Results
3.2.1. Confirmation of LA presence in A. sinensis
LA presence in A. sinensis was initially tested using PmxB assay, which binds
and removes LA from the herb solution. Our results show that activity of A. sinensis
decreased when exposed to pmxB based on the levels of ICAM-1 transcription in THP-1
upon treatment with the different samples (Figure 3.3). This suggests that LA is present
in the herbal solution and that its activity was impaired due to the binding affinity of
pmxB to the glycolipid. We concluded that LA is present and active in A. sinensis.
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Figure 3.3. ICAM-1 qRT-PCR of A. sinensis treated with polymyxin B. THP-1 cells were
treated with A. sinensis (AS) sample, AS treated with streptavidin resin (AS Mock), and AS with
polymyxin B (AS PmxB) all at 5 µg/mL. There was a significant loss in activity on AS PmxB
compared to Mock.

3.2.2. Primer selection for 16S rDNA sequencing.
To differentiate the various bacteria found in A. sinensis microbiota, we used 16S
ribosomal RNA gene (rDNA) sequencing.
Although the classic approach to characterizing the microbial community in A.
sinensis was culturing the organisms, sequencing was preferred over culturing because of
the high possibility of having non-culturable bacteria in the sample. The study had the
added challenge of a scarce bacteria population present in dry herbs, compared to whole
plants.
For our study three different samples of A. sinensis, labeled AS1-3, were used and
three different batches were chosen to study the correlation between batch variability and
bacteria population. DNA was extracted and the quality of the extracted DNA was
checked by 260/280 ratio. As expected, dry herbs had small amounts of DNA, although it
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was enough for amplification by PCR. A set of three well established 16S rDNA primers
were used for our metagenomic studies, namely, primer pairs PI (fM1/rC5), P2
(926F/1392R) and P3 (1114F/1392R). All have been successfully used to amplify and
sequence 16S rRNA gene in plant samples [26-29]. Specification for coverage, length
and expected size are on Table 3.1. Primer pairs had an overhang that was necessary to
create an Illumina library.

Table 3.1. List of primers used for metagenomic analysis.

Primer Name
fM1
rC5
926f
1114f
1392r

Sequence
ccgcgtgnrbgahgaaggyyyt
taatcctgtttgctccccac
actcaaaggaattgacgg
gcaacgagcgcaaccc
acgggcggtgtgtrc

16 locus
V3 start
V4 end
V5 start
V6 start
V8 end

Primers were paired in the following way: fM1/rC5, 926f/1392r, and 1114f/1392r. The nucleic
acids were defined as: a (adenine); c (cytosine); g (guanine); t (thymine); n (any nucleotide); r
(purine); b (any but adenine); h (any but guanine); y (pyrimidine).

Primer pairs for Illumina sequencing were chosen based on the following
criterion: specificity toward 16S rDNA amplification, amplification of multiple variable
regions, and amplicon fragment size of 300bp-600bp. Amplicon size requirements are
due to restrictions by the sequencer as well as for computational analysis. Illumina
sequencer can only handle short amplicons due to technological limitations. If the
amplicons are too short, there is no overlapping and joining the end-pair of the amplicons
would not be possible computationally. After choosing the primers, we tested and
optimized the reaction (Figure 3.4). One of the parameters we optimized was the
annealing temperature. Primer annealing in the Illumina protocol called for 55ºC,
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however, the amplification improved when we modified the temperature to 53-58ºC in
0.2ºC/sec increments. Optimization of PCR and quality check were necessary because the
added overhang could potentially have affected the amplification efficiency and increased
the size of the fragments.

Figure 3.4. PCR amplification of 16S rDNA in Angelica sinensis. Agar Gel stained with
ethidium bromide. Three samples of A. sinensis were tested using three different 16S rDNA
primer pairs (P1-P3). The 16S rDNA amplicons were seen at 450, 550, and 400 base pairs (bp)
for P1, P2, and P3, respectively. P2 also gave a larger band at 950 bp, which is probably of plant
origin (mitochondrial/chloroplast DNA).

3.2.3. Metagenomic Analysis
Library preparation, Illumina sequencing and data analysis was done by the
Genome Technology Center, at NYU Langone Medical Center.
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Figure 3.5. Quality score chart of the Illumina reads of the 16S rRNA amplicons from
Angelica sinensis. Also, known as Phred quality score. Most reads (72.1%) had the quality score
of 30 or higher. Quality score of 30 (Q30) means that base call accuracy is 99.9%. Q20 means
99%. Q10 is 90%. A low Phred quality score would increase the chances of having false-positive
variants.

Illumina data was analyzed using open source software Quantitative Insight Into
Microbial Ecology (QIIME) version 1.7 and 1.8 [30]. This software groups multiple
third-party tools for data analysis and data visualization. Data analysis was done using the
sequencing data obtained from Illumina (fastq file) and a mapping file, containing the
information about barcodes used for library preparation, primer sequences and samples
names. Fastq file and mapping file analyzed on QIIME were first pre processed by
removing primer and adapter sequences. During the pre processing step, the quality of the
data was also analyzed (Figure 3.5). The quality of the data was determined to be good,
with 72% of the reads above Q30 (Base call accuracy 99.9%). For data processing, only
amplicons >Q25 were considered. The amplicons sequences end-pair were then joined
and the data was further processed by grouping sequences into operational taxonomic
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units (OTUs). OTUs are grouped by similarity in sequence, and taxonomy was assigned
by cross referring the OTUs against GreenGenes Database (Figure 3.6).

Figure 3.6. QIIME workflow. This scheme shows how data was analyzed using QIIME. There
are mainly three processes in which data is analyzed and visualized. Sequencing data was
processed using mapping file as the source of barcode and primer sequence. Data analysis was
performed to assign OTU’s using GreenGenes Database as reference. After data analysis,
mapping file was used to create taxonomy charts.

QIIME analysis revealed that our primers were not as specific as anticipated, as
they amplified sequences belonging to chloroplasts and mitochondria from plant.
Specifically, P1 and P2 amplified plant mitochondria and chloroplast DNA, while P3
provided the most information about the bacterial community present in A. sinensis. The
information obtained from the P3 amplicons pointed us to Phylum: 21, Class: 59, Order:
108, Family: 219, Genus: 519 (Figure 3.7a). More specifically we the genera Rahnella,
Pseudomonas, Erwinia, Bacillus were detected more consistently in all the batches of A.
sinensis.
Pseudomonas is a very diverse genus, with pathogenic members, as well as plant
colonizing bacteria. They can be found in fresh water and soil. The genus Erwinia
consists mostly of plant pathogenic Gram-negative bacteria.
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Rahnella is a genus of gram-negative bacteria found in multiple environments,
such as soil, marshes, freshwater, plants, seeds, food and animals such as snails and
beetles. Rahnella helps the plants grow by fixing nitrogen, making phosphate more
soluble, and keeping harmful bacteria away [31].
Rahnella was the most abundant genus in all three samples of A. sinensis,
although the abundance varied from sample to sample (Figure 3.7b). Remarkably, the
abundance of Rahnella in A. sinensis appeared to be associated with the
immunostimulatory activity (Figure 3.7b,c). Undoubtedly the results gave us a glimpse
on the importance of bacteria in the activity of herbal formulations. At present we can
simply speculate that Rahnella is enriched in A. sinensis. Confirmation would require to
look at the bacterial population in living plants. Even though more studies are needed to
further characterize the potential correlation, the data give an insight on potential
environmental factors that may have a role in the clinical variability of different mixtures
and provide a possible approach for further investigation.
For the purpose of our study, however, the genus Rahnella was identified as the
perfect candidates for LA extraction. Furthermore, additional sequencing data analysis
showed that most of the readings were consistent with one particular Rahnella species,
Rahnella Aquatilis
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Figure 3.7. 16S metagenomic analysis of Angelica sinensis. (a) The diversity of bacterial
community in A. sinensis samples. (b) Bacterial genera identified in the three A. sinensis samples
(AS1, AS2, and AS3). For each sample, the shown result is the average of three independent
replicates. Rahnella was the predominant genus in all three A. sinensis samples. Although there
was a total of 16,263 Illumina reads for Rahnella, all reads were classified as Rahnella aquatilis.
(c) Immunostimulatory activity of three A. sinensis samples (AS1, AS2, and AS3). JTT (Juzentaiho-to, 100 μg/mL), an immune-boosting herbal formulation, was used as the positive control.
The activity was measured by qRT-PCR of ICAM-1 in THP-1 cells. THP-1 cells were treated
with samples (5 μg/mL) for four hours. RQ (Relative Quantitation): fold change.

3.3. Discussion
Our search for specific immunostimulatory components of JTT brought us to the
identification of the microbial community of one of JTT’s components, Angelica
sinensis. More specifically we found that Rahnella aquatilis was the more abundant
strain in A. sinensis, strongly indicating the species as one of the sources of the
immunostimulating activity exhibited by JTT. The use of metagenomic analysis to
identify the bacteria present in the plant was successful, but not without difficulties. The
primers used were not as specific to bacterial DNA as expected, leading to amplification
of chloroplast and mitochondria. The genetic material in chloroplast and mitochondria
closely resembles the one found in bacteria. We were able to reduce the effects of
chloroplast and mitochondria amplification, by eliminating these OTUs. There are new
technologies that prevent the amplification of chloroplast and mitochondria called PCR
blockers, or PNAs. These PNAs (pPNA for chloroplasts and mPNA for mitochondria)
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have high affinity to chloroplast and mitochondria sequence, preventing their
amplification by PCR. This might be a good method to prevent the same issues in
metagenomic of other JTT components.
Our group was the first to profile the microbial community in immunostimulatory
herbs. Our findings support the hypothesis that herbs are not directly or solely responsible
for the immunostimulanting activity, but that the enriched bacteria are important players
in the beneficial and curative effects in humans. Furthermore, these “herbal probiotics”
that we believe are key elements in JTT may have a role in other preparations as well.
More importantly our data highlight the importance of the bacteria symbiotic relationship
not just for the plants, but for human purposes independent from agriculture.
The discovery of a role for symbiotic bacteria in the curative effects of medicinal
herbs is of fundamental importance also for one of the main issue in the medicinal field
herbal medicine standardization. A known problem in the preparation of herbal
formulations is the variability between batches. As an example, in our study we tested 3
different batches of A. sinensis, two from Japan and one from China. Although, all three
batches showed good levels of activity (Figure 3.1), the ICAM-1 assay resulted in
consistent differences between the three samples. This suggests that the potency and
effectiveness of an herbal mixtures is dependent on harvesting location of the herbs, due
to on the soil and microbial composition as well as the climate conditions. The fact that
bacteria are important in the activity of these plants shines a light on why locations is so
important in the potency of the herb. We expect that, in the future, herbal formulations
would be improved by standardizing the microbiome.

48
Even though we focused our study on A. sinensis, it is important to mention that
we also worked with the two other JTT components that showed immunostimulating
activity (Figure 3.1). Peony lactiflora has been recently studied in another immune
boosting herbal preparation [32] showing potential for probiotic presence. Our attempt at
LA enrichment in Peony Radix, however, was unsuccessful. We expect bacteria to be
present in the root, although we were unable to enrich LA. The preparation of Peony root
in JTT can consist in peeling the roots and boiling for 5 to 10 min, likely eliminating
most of the bacteria. To test this in the future we might try to enrich a very fresh herbal
sample, a differently prepared sample, or the plant itself. The third component, cinnamon,
was difficult to work with due to solubility issues. It showed nevertheless immuneactivity, most likely caused by the fine particles that remained after filtration. We
unsuccessfully tried to isolate and amplify bacterial DNA from the sample. In retrospect,
cinnamon bark may not be in direct contact with significant number of bacteria, since
most bacteria are expected to be in the parts contacting the soil, hence the activity may
have a different source.
For our purposes, once we identified the main source of LA in A. sinensis as R.
aquatilis, we began to think about how to extract and determine the structure of the LA of
interest. Initially, we anticipated two main difficulties for the isolation of LA from the
plant. First, not enough material for analysis. Although small quantities of LA are needed
for MS analysis, much larger quantities would be required for NMR analysis. Second,
heterogeneity of LA. There is the possibility of having multiple LA isoforms in an
individual bacterial species [33]. In addition, the structure of LA is dependent on
temperature [34-36] and host interaction [37, 38]. This means there are possibly multiple
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LA variants within A. sinensis, which would be too diluted for extraction and structural
analysis. Thanks to our metagenomic data we could now corvumvent these problems by
isolating LA directly from bacteria.
Even though R. aquatilis has been found beneficial as a component of medicinal
herbs, it has also been linked to infection in immunocompromised patients [39, 40].
Unpublished data on R. aquatilis LPS show that it is endotoxic, although is not as toxic as
E. coli LPS. JTT, on the other hand, lacks any endotoxicity [41]. This opens the
possibility that factors from the plant that modulate the activity of LPS. This possibility
will be discussed further in the next chapter.

3.4. Materials and Methods
DNA extraction from Angelica sinensis. The study examined three samples of
A. sinensis (dried root) from China (AS1) and Japan (AS2 and AS3). The samples were
first ground to small (~2-5 mm) pieces. DNA was extracted using MoBio PowerLyzer ®
PowerSoil® DNA Isolation Kit using the manufacture’s protocol, to which minor
modifications were made. Dry A. sinensis sample (250 mg) was placed in a glass bead
tube with 500μL of nuclease free water. Hydrated sample was lysed by vortexing in the
glass-bead tube for 15min. From then, the manufacture’s protocol was followed until the
final elution step, in which 50μL of solution 6 (from the kit) was used to obtain
approximately 1.2-1.6 μg of DNA per sample. For each sample, DNA extraction was
carried out in three independent replicates.
PCR. The study examined three different primer pairs, namely, P1(fM1,
rC5)[26],

P2(926f/1392r),[3] and P3(1114f/1392r).[3] Primer sequences are shown

below. Each primer contained the overhang sequences for Illumina sequencing; the
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overhang of the forward primers was 5’-tcgtcggcagcgtcagatgtgtataagagacag-3’; the
reverse overhang was 5’-gtctcgtgggctcggagatgtgtataagagacag-3’. PCR reactions were
performed with 100 ng of extracted DNA. The PCR reaction mix incorporated the
following components for a 25µL reaction: 12.5µL KAPA HiFi HotStart ReadyMix (2×)
(KAPA Biosystems; Catalog # KR0370), 1µL forward primer, 1µL reverse primer,
required volume for ~100ng of template DNA, and the volume was adjusted to 25µL
with nuclease free water. The following PCR protocol was used: 95˚C for 3 minutes for
initial denaturation, followed by 30 cycles of: 95˚C for 30 seconds (denaturation), an
annealing ramp at 0.2˚C/second from 50-58˚C for 45 seconds, 72˚C for 1 minute
(extension); the final extension was at 72˚C for 10 minutes. The PCR products were
cooled to 4˚C. PCR amplicons were analyzed by electrophoresis (2% agarose).
Illumina sequencing. Bacterial 16S rDNA was amplified with the three primer
pairs P1 (fM1, rC5) [26], P2 (926f/1392r) [3], and P3 (1114f/1392r) [3], following the
Illumina 16S Metagenomic Sequencing Library Preparation protocol [42] with the
following modification: 250 ng of microbial/plant DNA mix was used as template, and
the following PCR amplification conditions were used: 3 minutes at 95°C initial
denaturation, followed by 30 cycles of: 30 seconds at 95°C, 15 seconds at 50°C, 10
seconds at 58°C, and 1 minute at 72°C, followed by a 2 minute final extension at 72°C.
Libraries were built using the Nextera protocol exactly as described in the Illumina 16S
Metagenomic Sequencing Library Preparation protocol, pooled, and run on a MiSeq
using a 600 cycle cartridge, as 2 × 300.
Data analysis. Microbial community profiling analyses were performed on reads
from the 2 × 300 Illumina MiSeq sequencing run. After quality analysis of the raw reads
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(Illumina BaseSpace) and fastq raw sequence file generation (bcl2fastq), the open-source
software, Quantitative Insights Into Microbial Ecology (QIIME) software versions 1.7
and 1.8 [43] was used on the NYULMC High Performance Computing cluster. QIIME
version 1.8 was used to join paired-end reads and de-multiplex barcodes with a Phred
quality score threshold of >Q25. QIIME version 1.7 was used for the rest of the
workflow: closed-reference operational taxonomic unit (OTU)-picking process using the
BLAST algorithm aligning reads against the GREENGENES (gg_otus-13_8-release)
97_otu database of known 16S bacterial sequences, followed by phylogenetic diversity
analysis with a default sampling depth of 1000 sequences per sample.
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Chapter 4 Role of plant material in LPS modulation
4.1 Introduction
Plants and bacteria are known to interact in ways that are often beneficial for both
organisms. Equally important, some of the products of these mutualistic interactions have
been found to be advantageous to humans as well. One way humans can benefit
indirectly from these interspecific interactions, is through increase in crop growth rate
and crop health. A more direct benefit for humans is found in herbal medicine where, as
we are discovering, bacteria and plant interaction can be fundamental for the production
of compounds beneficial for human health. For example, it was recently discovered that
the

immune-boosting

herbal

supplement

Echinacea

purpurea

contained

lipopolysaccharide (LPS), a known endotoxic glycolipid found in Gram-negative bacteria
[1]. More importantly, it was found that LPS load directly correlated to macrophage
activity caused by the herbal supplement [1-3]. Independently, our research suggested
that bacteria’s Lipid A (LA) is the key component in JTT active fraction, giving the herb
its immune modulating activity [4]. The low concentration of LA in the sample as well as
the heterogeneity of the herbal decoction hindered the isolation and structural
identification of LA. To minimize the heterogeneity problem of the full plant concoction,
analysis was simplified by focusing on individual herbs. This lead to the analysis of
individual plant components, finally focusing on Angelica sinensis, which was selected
due to its high ICAM-1 stimulation on THP-1 cell assay.
As previously mentioned in Chapter 3, in order to find the source of LPS we
performed metagenomic analysis on the herb, which revealed that bacteria Rahnella

55
aquatilis was most abundant in A. sinensis samples. Interestingly, the R. aquatilis load
appeared to correlate with the immune modulating activity of A. sinensis [4]. Our interest
in Kampo herbal formulations such as A. sinensis and JTT comes from their long tested
safety, therefore being possible source of novel and safe immunostimulants. Now it is
suspected that there are beneficial bacteria within the herbs that contributes to the
immune-boosting activity. We call these bacteria “herbal probiotic,” and we postulated
that R. aquatilis was the cause of this safe immune stimulating activity of A. sinensis. Our
finding suggests the importance of herbal probiotics not only in A. sinensis and JTT but
possibly in other medicinal herbs.
LPS is a known immune stimulating agent, which can normally lead to sepsis in
high concentrations [5-7]. R. aquatilis, although not reported as a pathogenic bacteria,
can be pathogenic in immunocompromised patients [8-10] and newborns [11]. The
observation of LPS as the main immunostimulatory factor in A. sinensis raises two
possibilities. (1) LPS of plant-associated bacteria are not toxic. (2) LPS of plantassociated bacteria are still toxic, but plant compounds attenuate the toxicity. The latter
possibility is more likely because LPS of R. aquatilis is known to be endotoxic, although
in-vivo studies show toxicity is lower than the E. coli LPS.
The activity of LPS with plant glycolipids and phytosterols can be affected by
factors such as aggregation, caused by the amphiphilic nature of glycolipids, forming
micelles, liposome or immune stimulating complexes (ISCOMs). Studies have linked the
size of aggregates to modulation of the immune response [12-14], and it’s also known
that LPS alone can form aggregates in solution. Based on this information, we
hypothesize that plant molecules can modulate the aggregation state of LPS,
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reducing its toxicity. The effect of aggregation and immunostimulation has been
observed previously by our lab (Figure 4.1). During the study of JTT active fraction, it
was found that when the fraction was divided into equal part, and resuspended in either
100% methanol or 90% methanol-water, aggregates formed which modulated the activity
of the mixture. In this case, the sample treated with 100% methanol formed smaller
particles which showed higher activity on ICAM-1 assay compared to 90% methanol, the
later forming bigger aggregates. At the time of this study the presence of LPS on the
fraction was unknown, and BSSG was the suspected immunostimulant. Now, knowing
the components at a molecular level can lead to a deeper understanding on how JTT
works.

Figure 4.1. Particle formation by JTT fraction. Samples with the same composition (from JTT
active fraction) were dissolved in 90%MeOH (sample ‘90%’) and 100%MeOH (sample ‘100%’).
Solvent was rapidly evaporated and aggregation was characterized by AFM and DLS. (A) The
‘90%’ sample showed mostly large BSSG aggregates. (B) The ‘100%’ solution mainly composed
of small nanoparticles. The insets in the AFM images are the height profiles of representative
particles. The lower DLS panels in (A) and (B) show the particle distributions, which were
consistent with the AFM results. Figure from Hasson et. al [13]

The idea of particle formation was further supported by another project done in
our lab (Figure 4.2). In it, a mixture of GluCer and ceramide showed decreased activity
over

period of 3h [15]. It was determined that the overall activity of the sample
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diminished over time, while the size of the particles decreased, supporting the idea of
liposome formation.

Figure 4.2. TEM images of GluCer/Cer mixture at t=0 and 3 hours (left) and EDXA
Netcounts spectra (right): GluCer/Cer was re-constituted in DMSO (1 μg/μl) then diluted in
Millipore water (final concentration = 5 μg/mL). Two 8 μl of GluCer/Cer mixture was placed on
a grid, then one 8 μl of 1% sodium phosphotungstate solution was added. The grid was air dried
before the measurement. Figure from Takaoka (unpublished [15])

We sought to test our hypothesis by studying mixtures of LPS with phytosteroids
and glycolipids, and examine their immunostimulatory activity using ICAM-1 qRT-PCR
assay. The molecular assembly of LPS was studied using dynamic light scattering (DLS)
and transmission electron microscopy (TEM). We now can potentially recreate the
original herb’s composition synthetically, getting closer to explaining how JTT works.
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Another way in which plant components could modulate the toxicity of LPS is by
decreasing the inflammatory response. Plant glycolipids and phytosterols have similar
structures to compounds with known anti-inflammatory activity [16-18]. The herbs’
richness in anti-inflammatory glycolipids must be important in modulating the
immunostimulatory activity of the plant as well. Herbal formulations are known to be
very heterogeneous, and this is a common problem in understanding how herbal medicine
acts because interaction of multiple components may be what leads to the overall effect
during treatment. A known example is probenecid and penicillin. Probenecid hinders the
transport of penicillin by binding and inhibiting organic anion transporters (OATs),
which are in charge of excreting metabolites [19]. This leads to penicillin lasting longer
in the blood stream [20, 21]. This effect is called synergistic effect, when a molecule can
potentiate the effect of another one. There is also an antagonistic effect, in which
molecules can inhibit the activity of other molecules. One example is the case of
aminoglycosides (i.e. gentamicin) with penicillin (i.e. piperacillin and carbenecillin). The
two compounds form an insoluble precipitate when used as a mixture lowering the
activity of both drugs [22-24].
In this chapter, we will discuss how we were able to determine how aggregation
affected LPS activity, as well as how activity of LPS was further modulated by exposing
LPS to solvent mixtures in order to change the aggregation state.

4.2. Results
4.2.1. LPS/LA extraction and ICAM-1 assay standardization.
In order to successfully test LPS activity using ICAM-1 assay, significant
quantities of R. aquatilis would need to be cultured and harvested. Instead of extracting
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LPS for preliminary studies, commercial E. coli LPS was acquired. E. coli LPS was
diluted to determine the concentration at which change in LPS activity would the greatest
for ICAM-1 assay. The ideal concentration was found to be 0.1 ng/mL. At this
concentration, any change in ICAM-1 level would be significant.

Figure 4.3. LPS titration. Optimal LPS concentration was determined using THP-1 assay. Five
samples ranging from 50 ng/mL to 0.1 ng/mL were used and compared to DMSO. Amount of
DMSO added was 10uL per well. DMSO was used as a negative control. LPS concentration is
labelled underneath the sample.

The activity of crude LPS from R. aquatilis was examined and compared to E.
coli LPS. Most studies use the hot phenol - water [25, 26] extraction method for LPS
extraction. This can be considered the standard method of LPS extraction, and its major
advantage is that it easily lyses bacterial cells without the use of physical lysis (e.g. lysis
column or French press). In our case, LPS was extracted using modified standard water phenol method, called tri-reagent extraction [27]. This method was selected because it
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limited the use of hot phenol, making it easier to perform at room temperature. Trireagent method was used to isolate and hydrolyze LPS to obtain LA for further analysis.
To determine if LA was successfully isolated from bacteria, THP-1 assay was
performed on the enriched LA fraction from E. coli (TOP10) and R. aquatilis (ATTC
33991). LA was also characterized by endotoxicity level, using limulus amebocyte lysate
(LAL) assay. Concentration of LA samples was dictated by the assumption that crude
product would have smaller amount of active LA for both cell treatment and LAL assay.
LAL assay suggested that LA from R. aquatilis is more endotoxic than E. coli LA at the
same concentration, although studies suggest R. aquatilis LA is less toxic but more
pyrogenic than E.coli LPS [28].

Figure 4.4. Activity of extracted LA from E. coli and R. aquatilis. ICAM-1 qRT-PCR of LA
extracts from R. aquatilis and E. coli were compared. THP-1 cells were treated with DMSO,
negative control; LPS (commercial sample, E. coli LPS, 0.1 ng/mL), positive control; E. Coli
crude LA extract (5 µg/mL); R. aquatilis crude LA extract (5 µg/mL).
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Table 4.1. LAL assay results.

Sample

Concentration (ng/mL)

EU/mL (mean±SD)

E. coli crude LA

4000

0.25±0.06

R. aquatilis crude LA

4000

1.50±0.15

0.8

1.24±0.03

E. coli LPS (commercial)

Presence of LA was detected by using LAL assay, Samples of E. coli crude LA (4 µg/mL) and R.
aquatilis crude LA (4 µg/mL) were added to the assay, with the addition of commercial E. coli
LPS (0.8 ng/mL). Absorbance at 405 nm was recorded and DMSO was used as background. LA
from R. aquatilis and E. coli was compared.

4.2.2. Mixture effect
Now that most of the components in the active fraction were identifies, ICAM-1
assay was performed to test for the activity of glycolipids as single, double or triple
mixture. But first, we needed to limit the number of component that would be used for
further analysis.
Due to complexity of the JTT mixture, we needed to limit the range of glycolipids
and phytosteroids that would be used for this study. Previously, some glycolipids and
phytosteroids found by our group were tested using our ICAM-1 assay. Glycolipids and
phytosteroids as a single or binary mixtures showed no significant immunostimulation
[15, 29]. We decided to use BSSG, DGDG, MGDG, and ß-GluCer for analysis with LPS.
One reason was availability, also their suspected anti-inflammatory activity, as well as
their abundance in the active JTT fraction. The glycolipids/phytosterol and LPS were
mixed so the final concentration during treatment was 5 µg/mL for the former and 0.1
ng/mL for the latter.
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Figure 4.5. Activity of glycolipid mixtures. ICAM-1 qRT-PCR.THP-1 cells were treated with
DMSO as negative control; LPS (0.1 ng/mL), positive control; BSSG (5 µg/mL); GluCer (5
µg/mL); DGDG (5 µg/mL); LPS+BSSG (0.1 ng/mL, 5 µg/mL); LPS+GluCer (0.1ng/mL, 5
µg/mL); LPS+DGDG (0.1 ng/mL, 5 µg/mL); LPS+MGDG (0.1 ng/mL, 5 µg/mL);
LPS+BSSG+DGDG (0.1 ng/mL, 5 µg/mL, 5 µg/mL); LPS+BSSG+MGDG (0.1 ng/mL, 5 µg/mL,
5µg/mL).

Mixtures of LPS/DGDG, LPS/MGDG and LPS/GluCer greatly increase the
upregulation of ICAM-1 compared to LPS alone (Figure 4.5). At the same time,
LPS/BSSG mixture has a more discrete activity compared to LPS. The addition of BSSG
to the more active binary mixtures LPS/DGDG and LPS/GluCer dramatically lowered the
activity of the mixture (LPS/DGDG/BSSG and LPS/DGDG/BSSG).
Although the activity modulation caused by GluCer, MGDG and DGDG was
significant, LPS/BSSG mixture was studied in more detailed because BSSG was the most
predominant component in the active fraction.
We proceeded to test if change in BSSG concentration would affect LPS. The
concentration of LPS was kept constant while BSSG was gradually increased from 0.5
µg/mL to 50 µg/mL. The typical glycolipid concentration during previous experiments
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was 5 µg/mL, because it reasonable to assume that that concentration related to common
herbal dosage of during herbal medicine consumption.

Figure 4.6. BSSG gradient with LPS. ICAM-1 qRT-PCR.THP-1 cells were treated with DMSO
as negative control; LPS (0.1ng/mL), positive control; LB which is LPS at a set concentration of
0.1 ng/mL + BSSG at concentrations ranging from 0.5 to 50 µg/mL.

As it was previously observed, LPS with BSSG mixture at a concentration of
5µg/mL would decrease ICAM-1 upregulation compared to LPS alone. Interestedly,
BSSG increased the activity of LPS at 0.5 µg/mL, making it clear that multiple factors
are at play, and these factors are concentration dependent. One of the factors at play is the
formation of micelles or liposomes.
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4.2.3. Molecular assembly as means of immune modulation
As reported by our lab, molecular assembly is a usual occurrence in the
identification of plant glycolipid and phytosterols by monocytes and macrophages. A
known example of particle forming compound is LPS. LPS at different concentrations
forms distinctive particles in water. Therefore, for studies of LPS in aqueous
environment, particle formation needs to be considered.
Dynamic Light scattering (DLS) was used to determine size of particles in
solution. Molecular assembly is time dependent effect, as observed in the GluCer/Cer
system [13, 30]. The stability of LPS after 3 h was tested, as well as the effects of time on
LPS assembly.

Figure 4.7. DLS of E. coli LPS. Samples of LPS were suspended in DMSO and added to water.
Concentration of LPS in solution was 0.1 ng/mL and 1 ng/mL. Multiple scans were averaged.
Most significant runs are shown. Measurements shown were performed at t =3h.

Table 4.2. Time effects on E. coli LPS particle size.

0h
[LPS]ng/mL
0.1
1

Size avg
408
368

3h
Pdi avg
0.076
0.411

Size avg
991
234

Pdi avg
0.428
0.209
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The ability of BSSG to form nanoparticles was studied as well. BSSG was more
stable in solution, without showing a significant size change over a 3-hour period., not
aggregating as in the case of LPS.

Size avg
157nm

Pdi avg
0.171

Figure 4.8. BSSG DLS. BSSG solution was resuspended in water to a final concentration of
5µg/mL Runs at time 0h, 1h and 3h were averaged and plotted.

In the case of BSSG there was no significant change in size over time. Particle
formation of the mixture of LPS and BSSG was measured as well. After mixing LPS and
BSSG, we observed a decrease in ICAM-1 activity compared to LPS alone. Extrangely
enough, the particles formed by the mixture are smaller than any of the starting elements
in solution (Figure 4.9). This lead us to further study molecular assembly as means of
immunoactivity modulation.
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a.

Figure 4.9. Particle formation can modulate LPS activity. (a) ICAM-1 qRT-PCR.THP-1 cells
were treated with DMSO as negative control; LPS (0.1 ng/mL), positive control; BSSG (5
µg/mL); LPS+BSSG (LB) (0.1 ng/mL, 5 µg/mL). (b) Size of glycolipids as determined by DLS.
Samples were dissolved in DMSO and resuspended in water.

4.2.4. Immune activity modulation by solvent manipulation.
The amphiphilic characteristic of LPS and BSSG is a key factor in molecular
assembly. Natural product consumption is mostly done by dissolving these molecules in
hot water, which would lead to particle formation by amphipathic molecules.
From previous observations done in our lab [13, 15], it became clear that solvent
manipulation could be used to modulate the activity of LPS. By resuspending LPS with
either 90% MeOH or 100% MeOH solution, compared to no resuspension, affected the
activity of the endotoxin.
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Figure 4.10. Solvent effect on LPS. Water solution of LPS was separated into 3 fractions.
Solvent was evaporated and samples were resuspended either with MeOH (L100), 90% MeOH
for (L90), or no solvent (L0). Samples were dried for 3 hours and re-constituted in DMSO. THP1 cells were treated with DMSO, negative control; L100 (0.1 ng/mL); L90 (0.1 ng/mL); L0 (0.1
ng/mL).

Although the difference between LPS in 100% MeOH and 90% MeOH in this
system was negligible, it was important to check how solvent affected LPS/BSSG
mixture as well. ICAM-1 qRTPCR was used to test the activity of LPS/BSSG mixture
resuspended in either 100% MeOH (LB100), and 90% MeOH (LB90) (Figure 4.12a).
There was a considerable decrease in immunoactivity from exposure to 90% MeOH,
which can be attributed to size change or surface charge, or both. DLS was used to test
for size and surface potential differences between LB100 and LB90. The size of the
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Figure 4.11 Sample preparation scheme. LPS and BSSG were mixed in Methanol, then divided
into equal parts. Samples were dried, and 100% MeOH was added to one tube, 90% MeOH to
another, and nothing was added to the third one. Solvent was dried again, and samples were
labeled as LB100, LB90 and LB0. All samples were resuspended in DMSO and cells were treated
with 10 µL of solution (LPS 0.1 ng/mL; BSSG 5 µg/mL). Same scheme applies to preparation of
LPS samples.

a.

b.

Figure 4.12. Solvent effect on LPS/BSSG. qRT-PCR analysis as well as DLS analysis of
LPS/BSSG in 100% methanol and 90% methanol was performed. a. ICAM-1 expression of
LPS/BSSG (LB) samples after 4h treatment. Samples were prepared by dividing equally
LPS/BSSG freshly prepared mixture, evaporated solvent, and resuspended in MeOH (LB100),
and 90%.MeOH (LB90). Samples were again dried, and re-constituted in DMSO. Cells were
treated with DMSO, negative control; LPS (0.1 ng/mL), positive control; LB100 (0.1 ng/mL LPS,
5 μg/mL BSSG); LB90 (0.1 ng/mL LPS, 5 μg/mL BSSG). b. Representative DLS spectrum of
LB90 and LB100 at t=2.5h. Peaks are labelled as peak 1 (91nm for LB100; 105nm for LB90) and
peak 2 (~5000nm).
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Figure 4.13. TEM of LPS/BSSG. Sample of LPS/BSSG in MeOH was re-constituted in DMSO
(1 μg/μl) then diluted in Millipore water (final concentration = 5 μg/mL). Two 8 μl of LPS/BSSG
mixture was placed on a grid, then one 8 μl of 1% sodium phosphotungstate solution was added.
The grid was air dried before the measurement.

In order to determine how solvent manipulation affected the assembly of
LPS/BSSG particles in water, DLS was used. Size of particles and surface are two of
multiple factors that can affect the immunostimulatory activity of the mixture. Because
particles were suspected to be time sensitive, DLS was also used to check for particles
aggregation (Figure 4.12b). The parameters obtained by DLS were Size average,
Polydispersion index (pdi), and Peaks of interest, in this case only 2 of them. Size
average values are equated to size, but it does not correlate to the real sizes we are seeing
in, for example, LB90 (Figure 4.14a). Although interesting, that’s not the complete
picture. Pdi describes how homogenous the sample are, for example if there is only
particles of a single size (monodisperse) or multiple sizes (polydisperse). Values of for
LB90 and LB100 within the range of 0.1-0.2 suggest a narrow size distribution.
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Interestingly, pdi for LB90 oscilates from 0.05 to 0.2, suggesting difference in
distribution over time (Figure 4.14b). From pdi values we suspected possible
aggregation, so to further understand the difference in distribution, we looked at isolated
sizes. LB90 and LB100 mainly got distributed between 2 sizes, described by Peak 1(90110nm) and Peak 2 (~5000nm). Peak 1 for LB90 and LB100 is constant throughout ~3h,
with the same size of 120nm for both. The main difference is at Peak 2, which represent
bigger particle formation. During the ~3h study, LB90 had bigger particles.
By correlating activity with size, we determined that there is a small but
significant difference between LB90 and LB100. Over time, the size increased.
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c.
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Figure 4.14 DLS of LPS/BSSG over time. LPS/BSSG resuspended in MeOH (LB100, orange)
and LPS/BSSG resuspended in 90% MeOH (LB90, blue) were analyzed by DLS. DLS was run
over a period of ~3h at room temperature. Samples were prepared by adding 10µL of either 100%
or 90% in 1mL of water, to a final concentration of LPS (0.1ng/mL)+BSSG(5µg/mL). a. Size
average. It describes the average size of the particles over time. It is an average of all particle
sizes in the sample. b. Polydispersion Index. Describes if different particles sizes are present
within the sample. Homogeneous size particle would have a small PDI (0.01-0.1, monodisperse)
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and heterogeneous collection of particles would have large PDI (>0.7, polydisperse). c. Peak 1.
Describes one of the particle present in the sample. Peak 1 is usually the most prevalent. d. Peak
2. Describes the second particles present in the sample. Peak 2 represents the second most
prevalent particle.

Effect of preparation in surface polarity. Aggregation in LB90 was tested by
measuring surface polarity of the particles using Zeta potential. LB90 had a surface
potential >-30mV, which is the characteristic of incipient stability. Similarly, LB100
particles also had a surface potential >-30mV, but in this case the surface becomes more
negative over time, reducing the change of aggregation.

Table 4.3 Zeta potential.

Zeta potential
Sample

0h

1h

3h

LB90

-20.5±0.9mV

-22.0±0.9mV

-20.7±0.6mV*

LB100

-20.5±0.7mV

-24.3±1.3mV

-26.7±1.8mV*

Data was collected for samples LB90 and LB100 at 0, 1 and 3 hours. All readings done at 25ºC.
*The difference between these samples was p < 0.05.

4.3. Discussion
In our study, we showed that the addition of plant glycolipids modulates the
activity of LPS. The formation of particles and aggregates greatly affected the activity of
LPS. This discovery focused our studies on size-activity relationship. The instability of
liposomes and the short lifespan made this study challenging. Particles formed by LPS
were quite stable, with an average size of 1000 nm at a concentration of 0.1 ng/mL. On
the other hand, LPS can also form bigger particles when concentrated to 1 ng/mL. Even
though DLS on LPS at higher concentration shows a large distribution at ~300 nm
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(Figure 4.7), most LPS molecules are likely part on the big particles at ~5000 nm. It
would be difficult to study the effect of LPS on any system without considering aggregate
formation and bimodal distribution. On the other hand, BSSG formed stable particles
with a size of ~157 nm at a higher concentration compared to LPS (5 µg/mL).
Particle formation was suspected as the cause of the modulation effect of plant
components with of LPS due to the previous studies done by our lab (Figure 4.1).
Formation of nanoparticles can lead to immunomodulation by activating different kinds
of immune cells, by changing uptake mechanisms [31] or by increasing the glycolipid
surface exposure [32]. When LPS was combined with BSSG, the particles formed were
closer to the size of BSSG by itself. It makes sense due to the fact that, the molecular
ratio of LPS/BSSG is 1/50,000. Therefore, BSSG modulated the activity of LPS by
decreasing the size of LPS particles from 1000 nm to 120 nm.
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Figure 4.15. Particle uptake. Particles can be uptaken by monocytes and macrophages
commonly in 2 ways, pinocytosis and phagocytosis. a. Pinocytosis is used by the cell while
absorbing liquids and small lipid particles. b. Receptor mediated endocytosis is specific and
consumes energy. Usually receptor mediated endocytosis is used during the uptake of larger
particles.

BSSG modulation of LPS toxicity can also be at cellular level. BSSG is a
phytosterol, ubiquitous part of plant membranes found in multiple plant extracts and
believed to possess anticancer activity [33, 34]. Phytosterols have been also used to lower
cholesterol levels in patients. In a more recent experiment, it was found that mice
pretreated with β-sitosterol had lower inflammatory cytokines after induced colitis [35],
although no activity was observed in other mice studies [36].
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We tried to further modulate the effects of LPS by trying to change the
aggregation state of LPS/BSSG particles using different solvents. We found that when
LB was prepared with either 100% MeOH or 90% MeOH, it showed a distinct difference
in ICAM-1 upregulation, being the case of the sample LB100 more active than LB90.
Very interesting effect because the ability of solvent to change the effects of LPS have
never been studied before. One of the main effects of the solvent was to change the size
of the particles in as well as changing their stability in aqueous environment. LB90 was
found to have an overall larger Z-average, meaning that the particles formed were bigger.
The size increase can be described as aggregation effect caused by the polarity of the
particle membrane (Figure 4.15). Even though LB100 and LB90 have particles with
120nm diameter, LB90 most likely was able to form less of them, because bigger
particles can sequester a large quantity of phytosterols and LPS.
In order to explain the effects of the solvent, we would have to consider
interactions at the molecular level. Rearrangement after evaporation of the remaining
water can explain why 90% methanol causes the formation of more unstable particles. As
the solvent evaporates, the glycolipids polar head group might get buried within the
nanoparticle, diminishing the electrostatic repulsion and favoring more hydrophobic
interactions in the aqueous environment. Based on this assumption, the more exposed
hydrophobic core of LPS would be more readily identified by TLRs, but the spatial
configuration of the acyl chains in the nanoparticle prevents the recognition.
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Figure 4.16 Particle formation scheme. Proposed particle formation of LPS and BSSG in 100%
MeOH and 90% MeOH. a. In the case of 90% MeOH, evaporation would concentrate water until
at the very end only water remains. The polar portion of the molecules (glucose and
polysaccharide) would be facing the solvent in this case. Upon further evaporation there is a
chance that the polar heads would come together and form other kind of particle. b. In the case of
100% MeOH, LPS and BSSG would form a layer on top of the solvent, in which the hydrophobic
portion of the molecules (acyl chains) would be contacting the solvent. Further evaporation would
lead a layer of glycolipids with acyl chains facing the walls of the tubes. c. LB90 in water.
Formation of more hydrophobic particles is expected, causing aggregation into bigger particles. d.
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LB100 in water. More stable particles are formed because of presence of hydrophilic groups
facing the polar solvent.

There is also the effect of aggregation. Polydispersion index (PDI) gives us an
idea on how much distribution of particles there is in the solvent. In the case 90%
methanol, pdi is unstable, suggesting aggregation over time. To understand why the
particles aggregate, we need to consider Zeta potential. Zeta-potential considers the
charge of the particle surface, and if there charge is close to zero, that means that they
particles can’t repel each other, forming larger aggregates. In the case of LB90, zeta
potential approaches zero over a 3h period. Interestingly enough, the fact that LB100 zeta
potential becomes more negative over time, suggests that the aggregates become more
stable.
There are examples of plant components being part of immunemodulating
particles. As an example, Quillaia saponin with cholesterol and other phospholipids can
form immune stimulating complexes (ISCOMs). ISCOMs are used to stimulate immune
response without triggering the inflammation making it an adjuvant. With this idea in
mind, this finding can open new research opportunities, such as the development of LPSbased adjuvant formulations with plant metabolites (analogous to ISCOMs). It can also
lead to strategies to prevent/treat acute and chronic endotoxemia.
Overall, we concluded that BSSG modulates the activity of LPS affecting the
aggregation state of LPS. This modulation can be further tuned by solvent manipulation.
As expected, the size as well as arrangement on nanoparticles are important factors to
consider during preparation of glycolipid mixtures. Size as well as surface polarity would
affect APCs recognition as well as the uptake of particles. Depending on the solvent used,
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the type of mixing and the use of sonication can dramatically alter the outcome. The size
difference as well as stability of nanoparticles formed in tandem with BSSG opens a new
chapter in immunomodulation, in this case by using solvent to change the molecular
rearrangement.

4.4. Materials and Methods
Materials.

Glucocerebrocide (Soy 98%),

digalactosyldiacylglycerol,

and

monogalactosyldiacylgycerol, were purchased from Avanti Polar Lipids Inc. E. coli LPS,
Nutrient broth medium, and Pierce LAL Chromogenic Endotoxin Quantitation Kit were
purchased from Life Technologies. E. coli TOP10 was provided by Loayza’s Lab, from
the biology department at Hunter College. R. aquatilis 33991 was obtained directly from
ATCC. BSSG was synthetized with the help of Dr. Steward Bachan. Organic solvents
were HPLC grade and were purchased either from VWR or Fisher Scientific.
Bacterial strains and growth conditions. E. coli (TOP 10) and R. aquatilis
(ATCC 33991) were grown on Nutrient broth medium (BD cat 234000). E. coli were
grown at 37ºC in shaker overnight, while R. aquatilis were grown at room temperature
overnight. Bacteria were centrifuged, and pellets were used for LA extraction.
Lipid A isolation using TRIzol reagent. Bacteria pellets (~10 mg) were
resuspended in TRIzol reagent (200 µL). The bacteria suspension was incubated at room
temperature for 15 min. The mixture was then washed with chloroform (200 µL) and two
layers formed. The tube was vortexed for 1 min, mixing the solution vigorously. The
mixture was left for 10 min at room temperature. The mixture was centrifuged 10 min at
12000g. The two phases appeared again, which were separated using a glass pipette. The
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organic layer was places in a clean 1.5 mL test tube, and washes with extra 100 µL of
chloroform two times. All the aqueous fractions were combined and acidified to a pH 4,
using acetic acid/sodium acetate buffer. The mixture was then placed on an oil bath at
100ºC for 2h. Hydrolysis was checked over time, using TLC. After hydrolysis, the
solution was transferred to a 1.5 mL Eppendorf tube. Tubes were centrifuged for 10 min
at 2000g, and liquid was decanted carefully. Small pellet was then washed with ethanol
(500 µL), centrifuged again for 10 min at 2000g, and solvent was decanted. Tube was
then placed in a high vacuum pump until dry.
LAL Endotoxicity Assay. Assay was performed exactly as suggested by Pierce
LAL Chromogenic Endotoxin Quantitation Kit protocol. Test was performed on a 96well
plate. Samples were dissolved in DMSO, then added to the well with Millipore water to a
concentration of 4 µg/mL. Absorbance was detected using the Powerwave HT Microplate
Spectrophotometer.
Dynamic Light Scattering. Sample was dissolved in DMSO to the following
concentrations: LPS (0.02ng/µL), BSSG (1µg/µL). 5 uL of the sample were then added to
1mL of Millipore water on a DSL cuvette.

Zetasizer Nano ZS. For general size

measurement, and average of 12 scans per run were repeated at least 5 times. All
measurements were done at room temperature. Results were analyzed and averaged using
Zetasizer Nano software. In the case of 3h studies, and average of 12 scans were
performed during ~75 scans.
Zeta potential. Sample was dissolved in DMSO to the following concentrations:
LPS (0.02 ng/µL), BSSG (1 µg/µL). 5 uL of the sample were then added to 1 mL of
Millipore water, then poured on a folded capillary cells. Capillary cell was filled with
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solution avoiding air bubbles. Zetasizer Nano ZS was used to measure Zeta potential
values. 12 scans per run were repeated at least 5 times, at different time points (0h, 1h,
3h). Zetasizer Nano software was used to analyze data.
Transmission Electron Microscopy. Sample was dissolved in DMSO to the
following concentrations: LPS (0.02 ng/µL), BSSG (1 µg/µL). Measurements were
performed at 200 kV on a JEM 2100 (jeol). 8 µL of sample were added to a 300-mesh
silicon monoxide coated copper grid, (TED Pella Inc., Redding, California, USA). Two
8-μl drops of 1% aqueous solution of sodium phosphotungstate (stain) were added and
finally an 8 μl drop of deionized water. The grid was allowed to dry for 1 min under
protective cover. Excess water was removed using filter paper.
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Chapter 5 Current studies and Future directions
5.1. Introduction
The presence of LPS in well-known immunostimulatory plants showcase the need
for more understanding of the bacteria in certain plants. LPS is still the most potent
immunostimulant available, and it has been utilized in adjuvant formulation, such as
complete Freund’s adjuvant (CFA). CFA consists on lysed mycobacteria with emulsified
oil. Even thou CFA is known to be quite harmful, it is still used in animals because it
consistently produces high titers of multiple antibodies. This consistency is important in
immunological studies.
Safety of LPS was the main question raised by our finding in the previous
chapter, but it was not completely answered. It was found that LPS immunological
activity can be decreased by the addition of plant compounds. Decreasing cell activation
does not mean the same as making LPS safe. An adjuvant should still be able to activate
APC cells. Unlike CFA, a safe derivative of LPS is monophosphoryl lipid A (MPL). The
lack of endotoxicity from MPL is linked to a TRIF pathway bias compared to MyD88
pathway.
The activation of different pathways by LPS is dependent on the binding of LA.
There are LA that bind but do not activate TLR4, binds and activates both MyD88 and
TRIF pathways and finally binding which activates only TRIF pathways. Examples are
showed in Figure 5.1
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Figure 5.1. Activation of MyD88 and TRIF pathways. Different Lipid A structures would
interact differently with TLR4. The interaction will either cause no signal, such as the case of
Lipid IVa, activation of both signal cascades such as the case of E. coli Lipid A, or signaling
through TRIF pathway, such as the case of MPL.

TLR4 would trigger one of two pathways, all depending on the structure and the
binding of the LA portion. In the case of Lipid IVa, it is an antagonist, binding without
triggering TLR4. On the other hand, E. coli LA triggers TLR4 so both MyD88 and TRIF
pathways are active. This leads in the end to the activation of the immune response as
well as a strong inflammation response. This is why E. coli LA can cause sepsis. The last
example would be MPL, which is able to bind to TLR4 and trigger mostly TRIF
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pathway. This causes the activation of the immune response without the harmful effects
of inflammation. This is how adjuvant activity is achieved.
The endotoxicity of LPS therefore is dependent on the structure of Lipid A. As
previously mentioned, R. aquatilis LPS proved to be endotoxic in LAL assay, even more
endotoxic than E. Coli. But this was extracted from R. aquatilis grown in agar, not in the
soil or close to the roots of the plants. Therefore, we need to understand a lot more about
bacteria and their growth in plants.
Bacteria are unicellular microorganisms, invisible to the human eye but found
everywhere. They can live in all different environments such as soil, deep underwater,
inside animals as well as inside plants. The characteristic that makes bacteria ubiquitous
is their ability to adapt. They are extremely resilient; for example, they can adapt to
changing environmental conditions by interacting with each other and forming biofilms.
It has been calculated that up to 50 million bacteria can be found on 1 gram of soil, and 1
million would be found on 1mL of seawater [1].
Generally, people associate the relationship of bacteria with humans to disease
and infection. As reported on 2013, at least 2 million people were seriously infected by
antibiotic resistant bacteria in the US which resulted in the death of at least 23,000 people
a year [2]. In addition, harmful bacteria can cause food poisoning [3, 4]. Food poisoning
can be caused by parasites and viruses as well, but bacteria are the most common cause
of infection. However, bacteria can be beneficial and valuable to humans as well. For
example, bacteria are used in the fermentation process of milk products such as yogurt,
and butter. Cheese and probiotics have been studied and found effective in the treatment
of gastrointestinal diseases.
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Bacteria can be found on the skin, mouth and gut of humans, in fact there may be
as many bacteria as human cells in our body [5].These bacteria are not identified as
pathogens by our immune system, this allows them to live within mammals and they has
been determined that they are in charge of keeping harmful bacteria at bay in our
digestive system as well as maintaining homeostasis [6-8]. Some studies have linked gut
microbiota to food digestion, health, and diabetes [9-11] as well being linked to obesity
and bowel inflammation [12-14].
In humans, bacteria trigger the innate immunity by interacting with mononuclear
phagocyte system (MPS) cells, such as macrophages and monocytic cells. These cells
identify patterns on the bacteria surface like flagella, peptidoglycans and other membrane
components. LPS, a component of gram negative bacteria membrane, is one of the most
potent and well-studied pathogen associated molecular patterns (PAMP) [15-18] ever
found. Even though LPS is known for its pathogenicity, structural modifications in the
molecule can lead to a mild immune response, or even to a lack of response. For
example, it has been observed that gut bacteria activate NK cells, stimulating the
clearance of harmful gut bacteria [19, 20]. Improvement in sequencing techniques have
brought more interest to the gut microbiota composition and effects [21-23] as well as
soil and plants bacteria.
The same fundamental symbiotic relationship seen between bacteria and humans
can be translated to bacteria and plants symbiosis. There are bacteria that live within the
roots of plants are called endophytes. There are also bacteria that is found on the
rhizosphere, which is the soil closely associated to the roots. It is known that endophytes
are necessary for the well-being of plants in general. They are important for nitrogen
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fixation in legumes, and have a role in protecting the roots from harmful bacteria and
fungi by secreting antibiotic [24, 25]. Although the importance of the functions of
bacteria in plants is understood, more research is needed to decipher how bacteria are
selectively enriched and be allowed to grow in plants.

5.2 Current and future studies.
LPS activity is modulated by plant glycolipid, such as BSSG, but now we need to
ask the next question: Can phytosterols and plant glycolipids decrease not only the total
activity of LPS, but decrease LPS endotoxicity? JTT is known to activate the immune
response, without being endotoxic. The mixture of LPS and BSSG might not be just a
weaken the endotoxin, but might be an active adjuvant with minimized toxicity.
In order to answer this question; we can propose to:
Study the effects of JTT components on R. aquatilis LPS. Although unlikely,
it’s possible that R. aquatilis grown while in contact with JTT components can make LPS
nontoxic but active. The enrichment could be the key factor in making LPS that is safe,
by excluding more harmful bacteria and allowing safe to thrive. Also, we might need to
replicate the environment in which R. aquatilis is grown naturally. Most likely, it grows
at a different pH due to the soil as well as more dry environment.
Determine how plant material affects MyD88/TRIF bias. ICAM-1 activation
can give us very limited information about the activity of the tested compounds. Our
assay was developed in order to test the immunostimulating effects of JTT. Cells had a
very similar gene profile after treatment with LPS and JTT. The main difference was in
the proinflammatory genes were not upregulated in the case of JTT. The problem is that
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we expect both compounds, LPS and JTT, to upregulate ICAM-1. In order to determine
which pathway has been activated by LPS and plant compound mixture, we need to look
at different genes[26-29]. Table 5.1 describe some of the options.

Table 5.1 Genes linked to MyD88 and TRIF signaling [27-29].

MyD88
INF-
IL-6
COX-2
Serpine 1
CXCL1

TRIF
MCP-1
CCL5
IL-10

We tried to study the pathways bias using three different probes: IL-6, COX-2 and
CCL5. Probes for IL-6 and COX-2, both for MyD88 pathway, were consistently
expressed in our assay. The problem in our case was to find a probe for TRIF pathway.
The problem was that THP-1 cells have a low basal level of CCL5, the probe that we
decided to use to check TRIF bias. Consequently, we needed to study the immune active
effects of LPS and BSSG in other cells, such as macrophages derived from THP-1 cells.
These macrophages can be obtained by using phorbol 12-myristate 13-acetate (PMA)[30,
31]. Although these cells had increased level of CCL5, they were less sensitive to LPS.
Studies with LPS at higher concentrations is currently being perfomed.
There are other effects of LPS and BSSG worth styding. For example, adjuvants
are also known to activate different T cells. While adjuvants activate Th2 cells, other
immunostimulant activate Th1 cells. Th1 cells more linked to inflammation.
These studies could one day decipher the complexity of herbal mixtures such as
JTT.
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